‌

US Patent 12129466 Compounds and methods for modulating UBE3A-ATS

Patent 12129466 was granted and assigned to Ionis Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
1
Current Assignee
Ionis Pharmaceuticals
Ionis Pharmaceuticals
1
Date Filed
January 14, 2022
1
Date of Patent
October 29, 2024
1
Patent Applicant
Ionis Pharmaceuticals
Ionis Pharmaceuticals
1
Patent Application Number
17576245
1
Patent Citations
‌
US Patent 7399845 6-modified bicyclic nucleic acid analogs
1
‌
US Patent 7427672 Artificial nucleic acids of n-o bond crosslinkage type
1
‌
US Patent 7491805 Conjugates and compositions for cellular delivery
1
‌
US Patent 7547684 5′-modified bicyclic nucleic acid analogs
1
‌
US Patent 7569686 Compounds and methods for synthesis of bicyclic nucleic acid analogs
1
‌
US Patent 7666854 Bis-modified bicyclic nucleic acid analogs
1
‌
US Patent 7696345 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
1
‌
US Patent 7723509 IRNA agents with biocleavable tethers
1
‌
US Patent 7741457 6-modified bicyclic nucleic acid analogs
1
‌
US Patent 7750131 5′-modified bicyclic nucleic acid analogs
1
•••
Patent Inventor Names
Paymaan Jafar-nejad
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
12129466
1
Patent Primary Examiner
‌
Kimberly Chong
1

Find more entities like US Patent 12129466 Compounds and methods for modulating UBE3A-ATS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.